Relationship between clinicopathological features and mucin phenotypes of advanced gastric adenocarcinoma

World Journal of Gastroenterology

Volumn 16, Issue 22, 2010, Pages 2764-2770

  Toki, Fumiaki ^a   Takahashi, Atsushi ^a   Aihara, Ryusuke ^a   Ogata, Kyoichi ^a   Ando, Hiroyuki ^a   Ohno, Tetsuro ^a   Mochiki, Erito ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenocarcinoma; Diffuse type; Gastric neoplasms; Mucins; Phenotype; Prognosis; Undifferentiated type

Indexed keywords

MUCIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; DIFFERENTIATED ADENOCARCINOMA; DIFFUSE TYPE ADENOCARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PHENOTYPE; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 77954257826     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i22.2764     Document Type: Article

References (29)

1. Tatematsu M, Furihata C, Katsuyama T, Miki K, Honda H, Konishi Y, Ito N. Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure. Cancer Res 1986; 46: 4866-4872
2. Saito K, Shimoda T. The histogenesis and early invasion of gastric cancer. Acta Pathol Jpn 1986; 36: 1307-1318
3. Tahara E. Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer 1995; 75: 1410-1417
4. Reis CA, David L, Nielsen PA, Clausen H, Mirgorodskaya K, Roepstorff P, Sobrinho-Simões M. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer 1997; 74: 112-121
5. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49
6. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann 1968; 59: 251-258
7. Members of Working Group in World Health Organization Classification of Tumors. Tumor of the stomach. In: Hamilton SR, Aaltonen LA, editors. Pathology and Genetics: Tumors of the Digestive System. Lyon, France: IARC Press, 2000: 37-52
8. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 13th ed. Tokyo: Kanahara Inc., 1996: 26
9. Endo Y, Tamura G, Mtoyama T, Ajioka Y, Watanabe H. Well-differentiated adenocarcinoma mimicking completetype intestinal metaplasia in the stomach. Hum Pathol 1999; 30: 826-832
10. Yoshikawa A, Inada Ki K, Yamachika T, Shimizu N, Kaminishi M, Tatematsu M. Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1998; 1: 134-141
11. Nakamura T, Yao T, Kabashima A, Nishiyama K, Maehara Y, Tsuneyoshi M. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma. Histopathology 2005; 47: 357-367
12. Shibata N, Watari J, Fujiya M, Tanno S, Saitoh Y, Kohgo Y. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Hum Pathol 2003; 34: 32-40
13. Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 2000; 89: 724-732
14. Yamazaki K, Tajima Y, Makino R, Nishino N, Aoki S, Kato M, Sakamoto M, Morohara K, Kaetsu T, Kusano M. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations. World J Gastroenterol 2006; 12: 3803-3809
15. Yamachika T, Inada K, Fujimitsu Y, Nakamura S, Yamamura Y, Kitou T, Itzkowitz SH, Werther JL, Miki K, Tatematsu M. Intestinalization of gastric signet ring cell carcinomas with progression. Virchows Arch 1997; 431: 103-110
16. Bamba M, Sugihara H, Kushima R, Okada K, Tsukashita S, Horinouchi M, Hattori T. Time-dependent expression of intestinal phenotype in signet ring cell carcinomas of the human stomach. Virchows Arch 2001; 438: 49-56
17. Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G. Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int 2001; 51: 165-171
18. Pinto-de-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinicobiological behaviour of gastric carcinoma. Virchows Arch 2002; 440: 304-310
19. Aihara R, Mochiki E, Nakabayashi T, Akazawa K, Asao T, Kuwano H. Clinical significance of mucin phenotype, betacatenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma. Br J Surg 2005; 92: 454-462
20. Kabashima A, Yao T, Maehara Y, Tsuneyoshi M. Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas. Gastric Cancer 2005; 8: 220-227
21. Barresi V, Vitarelli E, Grosso M, Tuccari G, Barresi G. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas. Eur J Histochem 2006; 50: 301-309
22. Tian MM, Zhao AL, Li ZW, Li JY. Phenotypic classification of gastric signet ring cell carcinoma and its relationship with clinicopathologic parameters and prognosis. World J Gastroenterol 2007; 13: 3189-3198
23. Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M, Kumagai K. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 2001; 61: 212-220
24. Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y, Tatematsu M. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol 2003; 129: 727-734
25. Tajima Y, Yamazaki K, Nishino N, Morohara K, Yamazaki T, Kaetsu T, Suzuki S, Kawamura M, Kumagai K, Kusano M. Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions. Br J Cancer 2004; 91: 1342-1348
26. Yamagishi M, Noda M, Tatsumi Y, Mukaisho K, Mitsufuji S, Sugihara H, Okanoue T, Hattori T. Correlation between cyclooxygenase-2, proliferative activity, and mucin phenotype in human advanced gastric cancer. J Gastroenterol 2004; 39: 1143-1149
27. Kim GH, Song GA, Park DY, Lee SH, Lee DH, Kim TO, Jo HJ, Heo J, Kang DH, Cho M. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype. Scan J Gastroenterol 2006; 41: 880-886
28. Shiroshita H, Watanabe H, Ajioka Y, Watanabe G, Nishikura K, Kitano S. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains. Pathol Int 2004; 54: 311-321
29. Watanabe G, Watanabe H, Ajioka Y, Shiroshita H, Nishikura K. Well-differentiated type adenocarcinomas of gastric mucin phenotype transform into intestinal type carcinomas. Stomach and Intestine 2003; 38: 693-700